{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:15:51Z","timestamp":1762251351843},"reference-count":33,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p>\u2713Reconstruction of extensive nerve defects is hampered by the amount of autogenous nerve tissue available for transplantation and by donor site morbidity. Nerve allografts, being of foreign origin and potentially unlimited in supply, provide a solution to these problems. Studies have shown that nerve allotransplants require immunosuppression only until end-organ connections are made and that immunosuppressant therapy may be subsequently discontinued with no negative effect on functional outcome. Also, recent experimental and clinical focus has been on shorter periods of immunosuppression in order to reduce risk, even stopping immunosuppression after regeneration has reached the distal suture line rather than before recovery of end-organ connections. In the pediatric population, the increased disease burden and increased potential for nerve regeneration as well as the frequent availability of a living related donor make allografts all the more attractive as solutions to nerve reconstructive problems. Nevertheless, the risks of immunosuppression must not be underemphasized, and they deserve more attention in the current nerve transplantation literature.<\/jats:p>\n<jats:p>The authors report on a child who, at the age of 1 year, received a nerve allograft from a living related donor who was positive for Epstein\u2013Barr virus (EBV). The child quickly developed a symptomatic EBV infection concurrent with immunosuppressant drug therapy. The immunosuppression regimen was stopped prematurely, and the patient suffered only a short illness, but the EBV infection could have developed into a life-threatening posttransplant lymphoproliferative disorder (PTLD). The patient is consequently predisposed to develop PTLD and will have to be monitored for the rest of his life. This case highlights the importance of considering the potentially fatal risks associated with this elective procedure. Future studies are needed to quantify and minimize this complication. Nevertheless, it should be weighed against the potential functional benefit from using nerve allografts.<\/jats:p>","DOI":"10.3171\/jns.2007.106.5.924","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:46:36Z","timestamp":1201178796000},"page":"924-928","source":"Crossref","is-referenced-by-count":8,"title":["Epstein\u2013Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor"],"prefix":"10.3171","volume":"106","author":[{"given":"Mikko","family":"Larsen","sequence":"first","affiliation":[{"name":"Departments of Orthopedic Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen T.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Departments of Orthopedic Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Y.","family":"Shin","sequence":"additional","affiliation":[{"name":"Departments of Orthopedic Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Spinner","sequence":"additional","affiliation":[{"name":"Departments of Orthopedic Surgery and"},{"name":"Neurosurgery, and the"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-1060924","series-title":"Restor Neurol Neurosci","first-page":"129","article-title":"Indefinite survival of peripheral nerve allografts after temporary Cyclosporine A immunosuppression","volume":"13","author":"Atchabahian","year":"1998"},{"key":"b2-1060924","series-title":"Microsurgery","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/(SICI)1098-2752(1998)18:6<379::AID-MICR7>3.0.CO;2-5","article-title":"Regeneration through long nerve grafts in the swine model","volume":"18","author":"Atchabahian","year":"1998"},{"key":"b3-1060924","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3171\/jns.2006.105.4.602","article-title":"Peripheral nerve regeneration through allografts compared with autografts in FK506-treated monkeys","volume":"105","author":"Auba","year":"2006"},{"key":"b4-1060924","series-title":"Transplant Proc","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1016\/S0041-1345(98)00804-5","article-title":"Peripheral nerve allografting: review of the literature with relevance to composite tissue transplantation","volume":"30","author":"Bain","year":"1998"},{"key":"b5-1060924","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2106\/00004623-200210000-00020","article-title":"The spectrum of complications of immunosuppression: is the time right for hand transplantation?","volume":"84","author":"Brenner","year":"2002"},{"key":"b6-1060924","series-title":"Plast Reconstr Surg","first-page":"36E","article-title":"Discussion in Jiang HQ, Wang Y, Hu XB, Li YS, Li JS: Composite tissue allograft transplantation of cephalocervical skin flap and two ears","volume":"115","author":"Butler","year":"2005"},{"key":"b7-1060924","series-title":"J Transpl Coord","first-page":"175","article-title":"Nerve transplantation: a father's final gift","volume":"9","author":"Fabian","year":"1999"},{"key":"b8-1060924","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0140-6736(99)00112-9","article-title":"Prospects for hand transplantation","volume":"353","author":"Foucher","year":"1999"},{"key":"b9-1060924","series-title":"Transplantation","first-page":"1721","article-title":"Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus","volume":"74","author":"Fridell","year":"2002"},{"key":"b10-1060924","series-title":"J Pediatr Gastroenterol Nutr","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00005176-200402000-00018","article-title":"Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients","volume":"38","author":"Ganschow","year":"2004"},{"key":"b11-1060924","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late post-transplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005"},{"key":"b12-1060924","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial","year":"2005"},{"key":"b13-1060924","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3171\/jns.2002.96.5.0924","article-title":"Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice","volume":"96","author":"Grand","year":"2002"},{"key":"b14-1060924","series-title":"J Reconstr Microsurg","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-2006-939929","article-title":"Living-donor nerve transplantation for global obstetric brachial plexus palsy","volume":"22","author":"Gruber","year":"2006"},{"key":"b15-1060924","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"264","article-title":"Post-transplant lymphoproliferative disorders","author":"Harris","year":"2001"},{"key":"b16-1060924","series-title":"Plast Reconstr Surg","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.prs.0000245341.71666.97","article-title":"Use of cold-preserved allografts seeded with autologous Schwann cells in the treatment of a long-gap peripheral nerve injury","volume":"119","author":"Hess","year":"2007"},{"key":"b17-1060924","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1227\/01.NEU.0000204319.37546.5F","article-title":"Nerve regeneration through nerve autografts and cold preserved allografts using tacrolimus (FK506) in a facial paralysis model: a topographical and neurophysiological study in monkeys","volume":"58","author":"Hontanilla","year":"2006"},{"key":"b18-1060924","series-title":"J Infect Dis","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/314764","article-title":"Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1","volume":"179","author":"Jenson","year":"1999"},{"key":"b19-1060924","series-title":"Cancer Res","first-page":"4302","article-title":"Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients","volume":"41","author":"Klein","year":"1981"},{"key":"b20-1060924","series-title":"J Pediatr Gastroenterol Nutr","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00005176-200110000-00005","article-title":"The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience","volume":"33","author":"Kogan-Liberman","year":"2001"},{"key":"b21-1060924","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3171\/jns.1996.84.4.0671","article-title":"Nerve allotransplantation following severe tibial nerve injury. Case report","volume":"84","author":"Mackinnon","year":"1996"},{"key":"b22-1060924","series-title":"Plast Reconstr Surg","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/00006534-200105000-00016","article-title":"Clinical outcome following nerve allograft transplantation","volume":"107","author":"Mackinnon","year":"2001"},{"key":"b23-1060924","series-title":"Plast Reconstr Surg","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/00006534-199210000-00024","article-title":"Clinical application of peripheral nerve transplantation","volume":"90","author":"Mackinnon","year":"1992"},{"key":"b24-1060924","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0306-4522(92)90146-S","article-title":"An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression","volume":"46","author":"Mackinnon","year":"1992"},{"key":"b25-1060924","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00005072-199405000-00013","article-title":"The fate of Schwann cells in peripheral nerve allografts","volume":"53","author":"Midha","year":"1994"},{"key":"b26-1060924","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999"},{"key":"b27-1060924","series-title":"Plast Reconstr Surg","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/01.PRS.0000153032.68405.DA","article-title":"Assessment of the immune response to dose of nerve allografts","volume":"115","author":"Sen","year":"2005"},{"key":"b28-1060924","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/00007890-199912270-00006","article-title":"Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression","volume":"68","author":"Shapiro","year":"1999"},{"key":"b29-1060924","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","article-title":"Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease","volume":"73","author":"Smets","year":"2002"},{"key":"b30-1060924","series-title":"Pediatr Transplant","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1034\/j.1399-3046.2002.02029.x","article-title":"Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management","volume":"6","author":"Smets","year":"2002"},{"key":"b31-1060924","series-title":"J Reconstr Microsurg","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1055\/s-2007-1006625","article-title":"Long-segment nerve allograft regeneration in the sheep model: experimental study and review of the literature","volume":"12","author":"Strasberg","year":"1996"},{"key":"b32-1060924","series-title":"Transplantation","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00007890-200201150-00019","article-title":"Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication","volume":"73","author":"Verschuuren","year":"2002"},{"key":"b33-1060924","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/106\/5\/article-p924.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/106\/5\/article-p924.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/106\/5\/article-p924.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T10:12:10Z","timestamp":1709979130000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/106\/5\/article-p924.xml"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":33,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.2007.106.5.924","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}